Dose ‐finding study of the checkpoint kinase 1 inhibitor, prexasertib, in Japanese patients with advanced solid tumors

Cancer Science,Volume 109, Issue 10, Page 3216-3223, October 2018.

Source: Cancer Science - October 4, 2018 Category: Cancer & Oncology Authors: Satoru Iwasa, Noboru Yamamoto, Kohei Shitara, Kenji Tamura, Nobuaki Matsubara, Masaomi Tajimi, Aimee B. Lin, Hiroya Asou, Zhihong Cai, Koichi Inoue, Yuko Shibasaki, Kanako Saito, Hiroki Takai, Toshihiko Doi Source Type: research